Effect of eplerenone according to duration of heart failure in EMPHASIS-HF: It is never too late to start an MRA in HFrEF

Back

ESC Professional Premium Access

Effect of eplerenone according to duration of heart failure in EMPHASIS-HF: It is never too late to start an MRA in HFrEF

Session: Insights from recent HFrEF trials 2

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor S. Matsumoto (Tokyo, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Shingo Matsumoto

Toho University, Tokyo (Japan)

0 follower

5 more presentations in this session

Diuretic use and outcomes in patients with HFrEF: Insights from the VICTORIA trial

Speaker: Doctor J. Ezekowitz (Edmonton, CA)

Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

Speaker: Doctor D. Vukadinovic (Homburg, DE)

Scar characterisation to predict arrhythmia and death in ischaemic cardiomyopathy: insights from the REVIVED trial

Speaker: Doctor H. Morgan (London, GB)

Impact of integrated care in patients with heart failure with reduced ejection fraction: a report from the WARCEF trial

Speaker: Associate Professor M. Proietti (Milan, IT)

A national heart failure initiative is associated with improved use of quadruple guideline-directed medical therapy

Speaker: Doctor A. Sauer (Kansas City, US)

Access the full session

Insights from recent HFrEF trials 2

Speakers: Doctor S. Matsumoto, Doctor J. Ezekowitz, Doctor D. Vukadinovic, Doctor H. Morgan, Associate Professor M. Proietti...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources